Mr Lilong Dong
Higher degree by research (PhD) student
Institute for Molecular Bioscience
+61 7 334 62385
Journal Articles
Hesping, Eva, Chua, Ming Jang, Pflieger, Marc, Qian, Yunan, Dong, Lilong, Bachu, Prabhakar, Liu, Ligong, Kurz, Thomas, Fisher, Gillian M., Skinner-Adams, Tina S., Reid, Robert C., Fairlie, David P., Andrews, Katherine T. and Gorse, Alain-Dominique J.P. (2022). QSAR classification models for prediction of hydroxamate histone deacetylase inhibitor activity against malaria parasites. ACS Infectious Diseases, 8 (1), 106-117. doi: 10.1021/acsinfecdis.1c00355
Liu, Ligong, Dong, Lilong, Bourguet, Erika and Fairlie, David P. (2021). Targeting Class IIa HDACs: insights from henotypes and inhibitors. Current Medicinal Chemistry, 28 (42), 8628-8672. doi: 10.2174/0929867328666210629160647
Ward, Ambber, Dong, Lilong, Harris, Jonathan M., Khanna, Kum Kum, Al-Ejeh, Fares, Fairlie, David P., Wiegmans, Adrian P. and Liu, Ligong (2017). Quinazolinone derivatives as inhibitors of homologous recombinase RAD51. Bioorganic and Medicinal Chemistry Letters, 27 (14), 3096-3100. doi: 10.1016/j.bmcl.2017.05.039
Thesis
Dong, Lilong (2021). Towards Selective Inhibitors of HDAC1 and HDAC7. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi: 10.14264/531cb05